<DOC>
	<DOC>NCT02268929</DOC>
	<brief_summary>This study is a German, prospective, multicenter, controlled, cluster-randomized, interventional comparative study evaluating the efficacy and benefits of integrated PDM care by measuring HbA1c levels in patients with Type 2 Diabetes. Patients will be randomized into two groups to use Accu-Chek Smartpix software and Accu-Chek Smartpix device.</brief_summary>
	<brief_title>A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Existence of a signed Informed Consent form (before any study procedure) Diagnosed Type 2 diabetes mellitus Age =18 years Insulin therapy for =6 months: BOT, SIT, CT or ICT HbA1c =7.5% within the last 6 weeks before study visit 1 (patient's inclusion) Longerterm diabetes care by the trial site (at least for the duration of the 12month study participation) General practitioner is the primary practitioner in the diabetes care of the patient Insured by the statutory health insurance (GKV) as a statutory or voluntarily insured member or as a family coinsured member Willing and able to participate in the study and to follow the study procedures, among other things sufficient command of the German language, spoken and written Diabetes treatment by insulin pump therapy (CSII) Experience with the use of special software for systematic processing of SMBG data, e.g. the AccuChek® Smart Pix System/Software, the AccuChek® 360° Software and/or the Diabetes Software DIABASS Presence of terminal renal failure / dialysis and/or a loss of sight or a tumor illness Chronic use of steroids in adrenal suppressant doses, of other immunomodulatory drugs or chemotherapy Known alcohol, drug and medication abuse Known metabolic disorders and/or disorders or therapies that could lead to or have led to wrong measured results (e.g. with the blood glucose measurement) Existing pregnancy, breastfeeding or plan to become pregnant during study participation Physical illness and/or psychological disorder with the result that the patient cannot implement the medical treatment recommendations independently Dependency relationship to the sponsor or to the investigator, e.g. as a professional colleague or family member</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>